Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Operating Leases (2019 - 2025)

Marimed (MRMD) has disclosed Operating Leases for 7 consecutive years, with $8.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases fell 9.66% to $8.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $8.8 million, a 9.66% decrease, with the full-year FY2024 number at $7.5 million, down 10.72% from a year prior.
  • Operating Leases was $8.8 million for Q3 2025 at Marimed, down from $9.1 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $10.6 million in Q1 2023 to a low of $4.2 million in Q4 2022.
  • A 5-year average of $7.1 million and a median of $7.5 million in 2024 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: skyrocketed 144.88% in 2023, then decreased 23.48% in 2024.
  • Marimed's Operating Leases stood at $4.6 million in 2021, then fell by 8.77% to $4.2 million in 2022, then soared by 102.61% to $8.5 million in 2023, then fell by 10.72% to $7.5 million in 2024, then rose by 16.77% to $8.8 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Operating Leases are $8.8 million (Q3 2025), $9.1 million (Q2 2025), and $7.3 million (Q1 2025).